Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from GSK

An Under the Radar Healthcare Stock to Add to Your Portfolio

The era of the giant pharmaceutical conglomerate is coming to a close, but consumer-focused Haleon stock looks set to deliver healthy returns through long-term economic cycles.

Barchart

Pharma Giant GSK Beats Second-Quarter Goals On Growth In Vaccines, General Medicines

Pharmaceutical giant GSK beat expectations for the second quarter and raised its forecast for the full year.

Investors Business Daily

FTSE 100 Live: NatWest boss out, Ocado shares surge further, Fed ups rates but markets hope it’s last hike

The turmoil at NatWest, half-year figures by Lloyds and profit upgrades at GSK and Rolls-Royce are just some of today’s big blue-chip developments.

Evening Standard

From analysis to the latest developments in health,
read the most diverse news in one place.

GSK leadership team meets KTR

The GSK team was excited to learn about the growth of the Lifesciences sector in Telangana and how global companies are leveraging the ecosystem.

The Hindu

‘This feels exactly the right place to be’: Sir Patrick Vallance on pandemics, eco-anxiety and leading the Natural History Museum

The UK’s former chief scientific adviser, a familiar face during Covid, talks about his new role as chair of the London museum and putting its collection at the heart of our climate response

The Guardian - UK

Panadol maker plans sweeping job cuts a year after being spun off from GSK

Exclusive: Consumer healthcare firm Haleon to cut hundreds of roles in UK and potentially thousands globally

The Guardian - UK

RSV vaccine for over-60s on the horizon after regulatory approval

RSV (respiratory syncytial virus) leads to around 8,000 deaths among people aged over 60 in the UK every year.

Evening Standard

Read news from The Economist, FT, and more,
with one subscription

Jab for common illness among over-60s on the horizon after regulatory approval

RSV (respiratory syncytial virus) leads to around 8,000 deaths among people aged over 60 in the UK every year.

The Independent UK

New vaccine for disease that kills 8,000 over 60s in UK every year

The vaccine will help cut up to 175,000 GP visits

Wales Online

Health warning as cases of little known disease skyrocket and 'tripledemic' looms

Health officials are endorsing two new vaccines against respiratory syncytial virus (RSV) for older Americans, alongside flu and Covid-19 vaccines, although there are uncertainties about the risks

Daily Mirror

Tech spending: The companies on London’s blue chip index exploring AI

A host of FTSE 100 companies are among businesses planning to invest in AI

Evening Standard

Older Americans can get RSV vaccine this fall after speaking with their doctor, CDC says

Americans 60 and older can get a new RSV vaccine but should discuss it with their doctor first

The Independent UK

‘Gamechanging’ TB vaccine within reach after $500m pledge to run final trials

Joint deal between Gates Foundation and Wellcome to develop M72 jab could save 8.5 million lives and prevent 76 million cases

The Guardian - UK

Gonorrhea shot gets FDA fast track as resistant cases multiply

GSK Plc’s experimental gonorrhea vaccine got fast-track designation from U.S. regulators, putting the shot in position to become the first preventive for a common, often-undetected infection that’s gaining resistance to treatment.

Tribune News Service

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

GSK Surges After Settling First Zantac Case, But A 'Conveyor Belt' Of Claims Looms

GSK stock jumped Friday after the British drugmaker said it settled one of thousands of claims that its heartburn drug Zantac caused cancer.

Evening Standard

How big pharma is using AI to untangle the language of DNA

AI-powered tools are rapidly transforming the world of drug discovery

Wales Online

GSK settles lawsuit over heartburn drug allegedly linked to cancer

The drug was owned by GSK but distribution was halted and it was recalled in 2019

Multichannel News

A+E Works With Ad Client GSK To Produce Meningitis B Awareness Film

Short features Soleil Moon Frye, Melissa Joan Hart

Get all your
news in one place.

100’s of premium titles.
One news app.

Fortune

Vivek Ramaswamy is threatening GOP heavyweights in the polls–but his business record doesn't live up to the hype

Yale's Sonnenfeld and Tian retrace presidential hopeful Vivek Ramaswamy's business record.

Fortune

GSK CEO Emma Walmsley says A.I. could improve Big Pharma's most 'profound' challenge: R&D inefficiency

"When we talk about health care costs, the single biggest thing we can do is innovate more.”

Fortune

GSK’s CEO says you need thick skin if you’re going to step into the C-suite

Emma Walmsley reflects on what it takes to lead a company through a turnaround.

Fortune

Why GSK's Emma Walmsley 'violently rejects' the idea of 'superhero' CEOs

In her mind, leadership is about inspiring collaboration.

Fortune

Being 'nature-positive' has been a hollow aim. That’s about to change

Move over, greenwashing (and greenwishing). Goodbye, vague nature goals. Enter science-based nature targets.

Daily Record

Giant turbines in South Ayrshire village would power Irvine pharmaceutical giant's factory

Residents debated whether to pragmatically embrace two turbines, which would power nearby GSK, planned for Dundonald.

The Independent UK

RSV vaccine for pregnant women protects their newborns but is it ready for US sale?

Federal health advisers are debating a first-of-its-kind RSV vaccine to protect newborns by immunizing their moms late in pregnancy

1 … 6 7 8 9

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Natural History Museum

121 stories

the Natural History Museum

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.